Haverford Trust Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Buy |
8,571
+2,657
| +45% | +$186K | 0.01% | 271 |
|
|
2025
Q1 | $435K | Buy |
5,914
+32
| +0.5% | +$2.35K | ﹤0.01% | 304 |
|
|
2024
Q4 | $385K | Sell |
5,882
-165
| -3% | -$10.8K | ﹤0.01% | 321 |
|
|
2024
Q3 | $471K | Sell |
6,047
-31
| -0.5% | -$2.42K | ﹤0.01% | 312 |
|
|
2024
Q2 | $474K | Buy |
6,078
+31
| +0.5% | +$2.42K | 0.01% | 301 |
|
|
2024
Q1 | $410K | Buy |
6,047
+1,600
| +36% | +$108K | ﹤0.01% | 307 |
|
|
2023
Q4 | $300K | Sell |
4,447
-1,412
| -24% | -$95.1K | ﹤0.01% | 327 |
|
|
2023
Q3 | $397K | Sell |
5,859
-319
| -5% | -$21.6K | ﹤0.01% | 283 |
|
|
2023
Q2 | $442K | Buy |
6,178
+606
| +11% | +$43.4K | 0.01% | 281 |
|
|
2023
Q1 | $387K | Buy |
5,572
+1,680
| +43% | +$117K | ﹤0.01% | 288 |
|
|
2022
Q4 | $264K | Sell |
3,892
-1,772
| -31% | -$120K | ﹤0.01% | 305 |
|
|
2022
Q3 | $311K | Sell |
5,664
-702
| -11% | -$38.5K | ﹤0.01% | 290 |
|
|
2022
Q2 | $421K | Sell |
6,366
-222
| -3% | -$14.7K | 0.01% | 254 |
|
|
2022
Q1 | $437K | Buy |
6,588
+1,772
| +37% | +$118K | 0.01% | 267 |
|
|
2021
Q4 | $281K | Buy |
4,816
+402
| +9% | +$23.5K | ﹤0.01% | 317 |
|
|
2021
Q3 | $265K | Buy |
4,414
+424
| +11% | +$25.5K | ﹤0.01% | 313 |
|
|
2021
Q2 | $239K | Sell |
3,990
-1,000
| -20% | -$59.9K | ﹤0.01% | 322 |
|
|
2021
Q1 | $248K | Hold |
4,990
| – | – | ﹤0.01% | 284 |
|
|
2020
Q4 | $249K | Buy |
+4,990
| New | +$249K | ﹤0.01% | 266 |
|
|
2014
Q1 | – | Sell |
-6,942
| Closed | -$206K | – | 212 |
|
|
2013
Q4 | $206K | Buy |
+6,942
| New | +$206K | 0.01% | 252 |
|